The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Davidson, Michael H.
One or more keywords matched the following items that are connected to Davidson, Michael H.
Item TypeName
Concept Anticholesteremic Agents
Academic Article Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia.
Academic Article Cost-effectiveness of pravastatin in secondary prevention of coronary artery disease.
Academic Article A psyllium-enriched cereal for the treatment of hypercholesterolemia in children: a controlled, double-blind, crossover study.
Academic Article Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial.
Academic Article Effectiveness of atorvastatin for reducing low-density lipoprotein cholesterol to National Cholesterol Education Program treatment goals.
Academic Article Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group.
Academic Article Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Atorvastatin Study Group I.
Academic Article A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.
Academic Article The cost of reaching National Cholesterol Education Program (NCEP) goals in hypercholesterolaemic patients. A comparison of atorvastatin, simvastatin, lovastatin and fluvastatin.
Academic Article Reduction of LDL cholesterol in patients with primary hypercholesterolemia by SCH 48461: results of a multicenter dose-ranging study.
Academic Article Safety profiles for the HMG-CoA reductase inhibitors: treatment and trust.
Academic Article A multiple-dose pharmacodynamic, safety, and pharmacokinetic comparison of extended- and immediate-release formulations of lovastatin.
Academic Article Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia.
Academic Article Cholesterol lowering with high-viscosity hydroxypropylmethylcellulose.
Academic Article Aggressive Lipid-Lowering Initiation Abates New Cardiac Events (ALLIANCE)-rationale and design of atorvastatin versus usual care in hypercholesterolemic patients with coronary artery disease.
Academic Article Colesevelam hydrochloride: a non-absorbed, polymeric cholesterol-lowering agent.
Academic Article Lipid-altering efficacy and safety of simvastatin 80 mg/day: worldwide long-term experience in patients with hypercholesterolemia.
Academic Article Cholesterol-lowering drugs bring benefits to high-risk populations even when LDL is normal.
Academic Article Comparison of the efficacy of atorvastatin versus cerivastatin in primary hypercholesterolemia.
Academic Article Effectiveness of colesevelam hydrochloride in decreasing LDL cholesterol in patients with primary hypercholesterolemia: a 24-week randomized controlled trial.
Academic Article High-molecular-weight hydroxypropylmethylcellulose taken with or between meals is hypocholesterolemic in adult men.
Academic Article Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels.
Academic Article Lipid and apolipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin.
Academic Article Management of hypercholesterolaemia in postmenopausal women.
Academic Article Combination therapy for dyslipidemia: safety and regulatory considerations.
Academic Article Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia.
Academic Article Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia.
Academic Article Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations.
Academic Article Use of a treatment algorithm to achieve NCEP ATP III goals with atorvastatin.
Academic Article A comparison of Canadian and American guidelines for lipid management using data from the National Cholesterol Education Program Evaluation ProjecT Utilizing Novel E-technology (NEPTUNE) II survey.
Academic Article Ethnic differences in achievement of cholesterol treatment goals. Results from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology II.
Academic Article Ezetimibe: a novel option for lowering cholesterol.
Academic Article Efficacy and safety of ezetimibe coadministered with statins: randomised, placebo-controlled, blinded experience in 2382 patients with primary hypercholesterolemia.
Academic Article Reducing the residual risk of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor therapy with combination therapy.
Academic Article The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.
Academic Article Should every patient with diabetes receive a statin?
Academic Article Combination therapy in the management of complex dyslipidemias.
Academic Article Novel nonstatin strategies to lower low-density lipoprotein cholesterol.
Academic Article Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
Academic Article Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction.
Academic Article Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.
Academic Article Low-density lipoprotein cholesterol reduction and goal achievement with ezetimibe/simvastatin versus atorvastatin or rosuvastatin in patients with diabetes, metabolic syndrome, or neither disease, stratified by National Cholesterol Education Program risk category.
Academic Article Reduced treatment success in lipid management among women with coronary heart disease or risk equivalents: results of a national survey.
Academic Article Focusing on high-density lipoprotein for coronary heart disease risk reduction.
Academic Article The use of colesevelam hydrochloride in the treatment of dyslipidemia: a review.
Academic Article Niacin use and cutaneous flushing: mechanisms and strategies for prevention.
Academic Article Atherosclerosis surrogate imaging trials come of age: for better or for worse?
Academic Article Statin and ezetimibe combination therapy in cardiovascular disease.
Academic Article Safety of anacetrapib in patients with or at high risk for coronary heart disease.
Academic Article One-year efficacy and safety of rosuvastatin + fenofibric acid combination therapy in patients with mixed dyslipidemia: evaluation of dose response.
Academic Article Is ezetimibe/simvastatin no better than simvastatin alone? Lessons learned and clinical implications.
Academic Article Focus on HDL as a therapeutic target for CAD risk reduction.
Academic Article Cholesterol absorption blockade with ezetimibe.
Academic Article Efficacy and safety of dalcetrapib in type 2 diabetes mellitus and/or metabolic syndrome patients, at high cardiovascular disease risk.
Academic Article Fluvastatin administration at bedtime versus with the evening meal: a multicenter comparison of bioavailability, safety, and efficacy.
Academic Article Hypercholesterolemia treatment patterns and low-density lipoprotein cholesterol monitoring in patients with a diagnosis of atherosclerosis in clinical practice.
Academic Article Safety and efficacy of ezetimibe added on to rosuvastatin 5 or 10 mg versus up-titration of rosuvastatin in patients with hypercholesterolemia (the ACTE Study).
Academic Article The efficacy and six-week tolerability of simvastatin 80 and 160 mg/day.
Academic Article A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women.
Academic Article Efficacy and safety of simvastatin 80 mg/day in hypercholesterolemic patients. The Expanded Dose Simvastatin U.S. Study Group.
Academic Article Low-dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low-density lipoprotein cholesterol in patients with primary hypercholesterolemia.
Academic Article Efficacy of simvastatin and ezetimibe in treating hypercholesterolemia.
Academic Article Newer pharmaceutical agents to treat lipid disorders.
Academic Article Emerging therapeutic strategies for the management of dyslipidemia in patients with the metabolic syndrome.
Academic Article Is it over for ezetimibe?
Academic Article Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: a phase 3 study.
Academic Article A review of the current status of the management of mixed dyslipidemia associated with diabetes mellitus and metabolic syndrome.
Academic Article A 50-week extension study on the safety and efficacy of colesevelam in adults with primary hypercholesterolemia.
Academic Article Update on CETP inhibition.
Academic Article Therapies targeting exogenous cholesterol uptake: new insights and controversies.
Academic Article Study design, rationale, and baseline characteristics: evaluation of fenofibric acid on carotid intima-media thickness in patients with type IIb dyslipidemia with residual risk in addition to atorvastatin therapy (FIRST) trial.
Academic Article Fluvastatin Long-Term Extension Trial (FLUENT): summary of efficacy and safety.
Academic Article Aggressive versus moderate lipid-lowering therapy in postmenopausal women with hypercholesterolemia: Rationale and design of the Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES) trial.
Academic Article Cost effectiveness of treatment to National Cholesterol Education Panel (NCEP) targets with HMG-CoA reductase inhibitors. Trial design.
Academic Article Diagnosis and treatment of familial hypercholesterolaemia.
Academic Article Dyslipidaemia: PCSK9 antibodies: a dividend of the genomics revolution.
Academic Article Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans.
Academic Article Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial.
Academic Article Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial.
Academic Article Evaluation of lipids, drug concentration, and safety parameters following cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib in patients with or at high risk for coronary heart disease.
Academic Article Use of microsomal triglyceride transfer protein inhibitors in patients with homozygous familial hypercholesterolemia: translating clinical trial experience into clinical practice.
Academic Article The efficacy of colesevelam HCl in the treatment of heterozygous familial hypercholesterolemia in pediatric and adult patients.
Academic Article Effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: a randomized, controlled, double-blind trial.
Academic Article Role of Ezetimibe in Lipid-Lowering and Cardiovascular Disease Prevention.
Academic Article Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab With Control.
Academic Article The Effect of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Sterol Absorption Markers in a Cohort of Real-World Patients.
Academic Article Can We Cure Atherosclerosis?
Academic Article Lower On-Treatment Low-Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials.
Academic Article Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials).
Academic Article PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety.
Academic Article Lipoprotein(a) reductions from PCSK9 inhibition and major adverse cardiovascular events: Pooled analysis of alirocumab phase 3 trials.
Academic Article Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus control.
Academic Article Reducing residual cardiovascular risk with novel therapies.
Academic Article Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm - 2020 Executive Summary.
Academic Article Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial.
Search Criteria
  • Anticholesteremic Agents